South Korea Fines Novartis $48M Over Bribes To Doctors
South Korea's Ministry of Health and Welfare has fined Novartis 55 billion South Korean won ($48 million) and stopped reimbursements for the Alzheimer's drug Exelon and chemotherapy drug Zometa after six...To view the full article, register now.
Already a subscriber? Click here to view full article